BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chung YC, Huang JH, Lai CW, Sheng HC, Shih SR, Ho MS, Hu YC. Expression, purification and characterization of enterovirus-71 virus-like particles. World J Gastroenterol 2006; 12(6): 921-927 [PMID: 16521221 DOI: 10.3748/wjg.v12.i6.921]
URL: https://www.wjgnet.com/1007-9327/full/v12/i6/921.htm
Number Citing Articles
1
Hu Dong, Hui-Chen Guo, Shi-Qi Sun. Virus-like particles in picornavirus vaccine developmentApplied Microbiology and Biotechnology 2014; 98(10): 4321 doi: 10.1007/s00253-014-5639-1
2
Xi Wang, Ke Dong, Min Long, Fang Lin, Zhaowei Gao, Lin Wang, Zhe Zhang, Xi Chen, Ying Dai, Huiping Wang, Huizhong Zhang. Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71Archives of Virology 2018; 163(7): 1851 doi: 10.1007/s00705-018-3797-7
3
Chia-Chyi Liu, Chyi-Sing Hwang, Wun-Syue Yang, Dan-Chin Tsai, Sze-Hsien Wu, Ai-Hsiang Chou, Yen-Hung Chow, Suh-Chin Wu, Jen-Ren Wang, Jen-Ron Chiang, Chin-Cheng Huang, Chien-Hsiung Pan, Pele Chong, Shan Lu. Long-Term Immunogenicity Studies of Formalin-Inactivated Enterovirus 71 Whole-Virion Vaccine in MacaquesPLoS ONE 2014; 9(9): e106756 doi: 10.1371/journal.pone.0106756
4
Shih-Yeh Lin, Li-Yu Sung, Chia-Tsui Yeh, Cheng-Ping Yu, Jyh-Yuan Yang, Yu-Chen Hu. Production and purification of virus-like particles of different enterovirus subtypes as vaccinesJournal of the Taiwan Institute of Chemical Engineers 2018; 82: 1 doi: 10.1016/j.jtice.2017.10.020
5
Ikbel Hadj Hassine, Jawhar Gharbi, Bechr Hamrita, Mohammed A. Almalki, José Francisco Rodríguez, Manel Ben M’hadheb. Characterization of Coxsackievirus B4 virus-like particles VLP produced by the recombinant baculovirus-insect cell system expressing the major capsid proteinMolecular Biology Reports 2020; 47(4): 2835 doi: 10.1007/s11033-020-05333-6
6
Stewart Goodwin, Tobias J. Tuthill, Armando Arias, Richard A. Killington, David J. Rowlands. Foot-and-Mouth Disease Virus Assembly: Processing of Recombinant Capsid Precursor by Exogenous Protease Induces Self-Assembly of Pentamers In Vitro in a Myristoylation-Dependent MannerJournal of Virology 2009; 83(21): 11275 doi: 10.1128/JVI.01263-09
7
Cheng-Yu Chung, Chi-Yuan Chen, Shih-Yeh Lin, Yao-Chi Chung, Hsin-Yi Chiu, Wei-Kuang Chi, Yu-Li Lin, Bor-Luen Chiang, Wei-Jheng Chen, Yu-Chen Hu. Enterovirus 71 virus-like particle vaccine: Improved production conditions for enhanced yieldVaccine 2010; 28(43): 6951 doi: 10.1016/j.vaccine.2010.08.052
8
Yu-Li Lin, Yu-Chen Hu, Cheng-Chao Liang, Shih-Yeh Lin, Yu-Chih Liang, Hui-Ping Yuan, Bor-Luen Chiang, Cheryl A. Stoddart. Enterovirus-71 Virus-Like Particles Induce the Activation and Maturation of Human Monocyte-Derived Dendritic Cells through TLR4 SignalingPLoS ONE 2014; 9(10): e111496 doi: 10.1371/journal.pone.0111496
9
A. Roldão, A.C. Silva, M.C.M. Mellado, P.M. Alves, M.J.T. Carrondo. Comprehensive Biotechnology2017; : 633 doi: 10.1016/B978-0-12-809633-8.09046-4
10
L. Zhang, N.J. Parham, F. Zhang, M. Aasa-Chapman, E.A. Gould, H. Zhang. Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditisVaccine 2012; 30(13): 2301 doi: 10.1016/j.vaccine.2012.01.061
11
Qunying Mao, Nan Li, Xiang Yu, Xin Yao, Fengxiang Li, Fengmin Lu, Hui Zhuang, Zhenglun Liang, Junzhi Wang. Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71Archives of Virology 2012; 157(1): 37 doi: 10.1007/s00705-011-1136-3
12
Jesús Zepeda-Cervantes, Adolfo Cruz-Reséndiz, Alicia Sampieri, Rosalba Carreón-Nápoles, José Iván Sánchez-Betancourt, Luis Vaca. Incorporation of ORF2 from Porcine Circovirus Type 2(PCV2) into genetically encoded nanoparticles as a novel vaccine using a self-aggregating peptideVaccine 2019; 37(14): 1928 doi: 10.1016/j.vaccine.2019.02.044
13
Jimmy A Mena, Amine A Kamen. Insect cell technology is a versatile and robust vaccine manufacturing platformExpert Review of Vaccines 2011; 10(7): 1063 doi: 10.1586/erv.11.24
14
A. Roldão, A.C. Silva, M.C.M. Mellado, P.M. Alves, M.J.T. Carrondo. Comprehensive Biotechnology2011; : 625 doi: 10.1016/B978-0-08-088504-9.00072-6
15
Peng-Nien Huang, Shin-Ru Shih. Update on enterovirus 71 infectionCurrent Opinion in Virology 2014; 5: 98 doi: 10.1016/j.coviro.2014.03.007
16
Natasha Kushnir, Stephen J. Streatfield, Vidadi Yusibov. Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical developmentVaccine 2012; 31(1): 58 doi: 10.1016/j.vaccine.2012.10.083
17
S. H. Basagoudanavar, M. Hosamani, R. P. Tamil Selvan, B. P. Sreenivasa, P. Saravanan, B. K. Chandrasekhar Sagar, R. Venkataramanan. Development of a liquid-phase blocking ELISA based on foot-and-mouth disease virus empty capsid antigen for seromonitoring vaccinated animalsArchives of Virology 2013; 158(5): 993 doi: 10.1007/s00705-012-1567-5
18
Zeinab Shirbaghaee, Azam Bolhassani. Different applications of virus‐like particles in biology and medicine: Vaccination and delivery systemsBiopolymers 2016; 105(3): 113 doi: 10.1002/bip.22759
19
Dan Yan, Yan-Quan Wei, Hui-Chen Guo, Shi-Qi Sun. The application of virus-like particles as vaccines and biological vehiclesApplied Microbiology and Biotechnology 2015; 99(24): 10415 doi: 10.1007/s00253-015-7000-8
20
Chih-Yeu Fang, Chia-Chyi Liu. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth diseaseExpert Review of Vaccines 2018; 17(9): 819 doi: 10.1080/14760584.2018.1510326
21
L. Pedro, S. S. Soares, G. N. M. Ferreira. Purification of BionanoparticlesChemical Engineering & Technology 2008; 31(6): 815 doi: 10.1002/ceat.200800176
22
Chenglei Li, Joseph Che-Yen Wang, Milton W. Taylor, Adam Zlotnick. In Vitro Assembly of an Empty Picornavirus Capsid follows a Dodecahedral Path Journal of Virology 2012; 86(23): 13062 doi: 10.1128/JVI.01033-12
23
Shih-Yeh Lin, Yao-Chi Chung, Yu-Chen Hu. Update on baculovirus as an expression and/or delivery vehicle for vaccine antigensExpert Review of Vaccines 2014; 13(12): 1501 doi: 10.1586/14760584.2014.951637
24
Xiaowen Wang, Xiangqian Xiao, Miao Zhao, Wei Liu, Lin Pang, Xin Sun, Shan Cen, Burton B. Yang, Yuming Huang, Wang Sheng, Yi Zeng. EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challengeBMC Research Notes 2016; 9(1) doi: 10.1186/s13104-015-1780-x
25
Hye-Jin Kim, Ho Sun Son, Sang Won Lee, Youngsil Yoon, Ji-Yeon Hyeon, Gyung Tae Chung, June-Woo Lee, Jung Sik Yoo, Florian Krammer. Efficient expression of enterovirus 71 based on virus-like particles vaccinePLOS ONE 2019; 14(3): e0210477 doi: 10.1371/journal.pone.0210477
26
Zhijian Yang, Fan Gao, Xiaoliang Wang, Likang Shi, Zheng Zhou, Yuanxiang Jiang, Xinxing Ma, Chao Zhang, Chenliang Zhou, Xianfang Zeng, Ge Liu, Jiang Fan, Qunying Mao, Li Shi. Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in Pichia pastoris Human Vaccines & Immunotherapeutics 2020; 16(7): 1602 doi: 10.1080/21645515.2019.1649554
27
Yangang Pan, Fuxian Zhang, Liuyang Zhang, Shuheng Liu, Mingjun Cai, Yuping Shan, Xianqiao Wang, Hanzhong Wang, Hongda Wang. The Process of Wrapping Virus Revealed by a Force Tracing Technique and SimulationsAdvanced Science 2017; 4(9) doi: 10.1002/advs.201600489
28
Mei-Ling Li, Shin-Ru Shih, Blanton S. Tolbert, Gary Brewer. Enterovirus A71 VaccinesVaccines 2021; 9(3): 199 doi: 10.3390/vaccines9030199
29
Fabiana Fernandes, Ana P Teixeira, Nuno Carinhas, Manuel JT Carrondo, Paula M Alves. Virus-like Particles in Vaccine Development2014; : 120 doi: 10.2217/fmeb2013.13.67
30
Chaoyun Shen, Zhiqiang Ku, Yu Zhou, Dapeng Li, Lili Wang, Ke Lan, Qingwei Liu, Zhong Huang. Virus-like particle-based vaccine against coxsackievirus A6 protects mice against lethal infectionsVaccine 2016; 34(34): 4025 doi: 10.1016/j.vaccine.2016.06.028
31
Zhenglun Liang, Qunying Mao, Qiang Gao, Xiuling Li, Chenghong Dong, Xiang Yu, Xin Yao, Fengxiang Li, Weidong Yin, Qihan Li, Xinliang Shen, Junzhi Wang. Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccinesVaccine 2011; 29(52): 9668 doi: 10.1016/j.vaccine.2011.10.018
32
Stanislav Sokolenko, Steve George, Andreas Wagner, Anup Tuladhar, Jonas M.S. Andrich, Marc G. Aucoin. Co-expression vs. co-infection using baculovirus expression vectors in insect cell culture: Benefits and drawbacksBiotechnology Advances 2012; 30(3): 766 doi: 10.1016/j.biotechadv.2012.01.009
33
Young-Joon Ko, Hyang-Sim Lee, Hye-Young Jeoung, Eun-Jeong Heo, Hyo-Rim Ko, Byung-Sik Chang, Hoo-Don Joo, U. Gerelmaa, B. Dashzeveg, S. Tserendorj, R. Sodnomdarjaa, Jong-Hyeon Park, Chang-Hee Kweon, In-Soo Cho, Sang-Gi Paik. Use of a Baculovirus-Expressed Structural Protein for the Detection of Antibodies to Foot-and-Mouth Disease Virus Type A by a Blocking Enzyme-Linked Immunosorbent AssayClinical and Vaccine Immunology 2010; 17(1): 194 doi: 10.1128/CVI.00374-09
34
Qin Yan, Linjuan Wu, Longyun Chen, Yali Qin, Zishu Pan, Mingzhou Chen. Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challengesVaccine 2016; 34(35): 4196 doi: 10.1016/j.vaccine.2016.06.058
35
Stacey E. Lynch, James R. Gilkerson, Sally J. Symes, Jin-an Huang, Liliana Tatarczuch, Carol A. Hartley. Equine rhinitis A virus-like particle expressing DNA vaccine induces a virus neutralising immune response in miceVirus Research 2011; 158(1-2): 294 doi: 10.1016/j.virusres.2011.04.009
36
Jing-Yi Lin, Yu-An Kung, Shin-Ru Shih. Antivirals and vaccines for Enterovirus A71Journal of Biomedical Science 2019; 26(1) doi: 10.1186/s12929-019-0560-7
37
Yao-Chi Chung, Mei-Shang Ho, Jaw-Chin Wu, Wei-Jheng Chen, Jen-Huang Huang, Szu-Ting Chou, Yu-Chen Hu. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challengeVaccine 2008; 26(15): 1855 doi: 10.1016/j.vaccine.2008.01.058
38
Balaji Somasundaram, Linda HL Lua. Development of picornavirus-like particle vaccinesPharmaceutical Bioprocessing 2015; 3(1): 45 doi: 10.4155/pbp.14.39
39
Shih-Yeh Lin, Hsin-Yi Chiu, Bor-Luen Chiang, Yu-Chen Hu. Development of EV71 virus-like particle purification processesVaccine 2015; 33(44): 5966 doi: 10.1016/j.vaccine.2015.04.077
40
Zhenglun Liang, Qunying Mao, Fan Gao, Junzhi Wang. Progress on the research and development of human enterovirus 71 (EV71) vaccinesFrontiers of Medicine 2013; 7(1): 111 doi: 10.1007/s11684-012-0237-z
41
Shih-Yeh Lin, Yao-Chi Chung, Hsin-Yi Chiu, Wei-Kuang Chi, Bor-Luen Chiang, Yu-Chen Hu. Evaluation of the stability of enterovirus 71 virus-like particleJournal of Bioscience and Bioengineering 2014; 117(3): 366 doi: 10.1016/j.jbiosc.2013.08.015
42
Yu-Ju Lin, Wen-Ti Liu, Holger Stark, Ching-Tsan Huang. Expression of enterovirus 71 virus-like particles in transgenic enoki (Flammulina velutipes)Applied Microbiology and Biotechnology 2015; 99(16): 6765 doi: 10.1007/s00253-015-6588-z
43
Shih‐Yeh Lin, Chia‐Tsui Yeh, Wan‐Hua Li, Cheng‐Ping Yu, Wen‐Chin Lin, Jyh‐Yuan Yang, Hsueh‐Ling Wu, Yu‐Chen Hu. Enhanced enterovirus 71 virus‐like particle yield from a new baculovirus designBiotechnology and Bioengineering 2015; 112(10): 2005 doi: 10.1002/bit.25625
44
Prabuddha S. Pathinayake, W. A. Gayan Chathuranga, Hyun-Cheol Lee, Mohammed Y. E. Chowdhury, Moon-Hee Sung, Jong-Soo Lee, Chul-Joong Kim. Inactivated enterovirus 71 with poly-γ-glutamic acid/Chitosan nano particles (PC NPs) induces high cellular and humoral immune responses in BALB/c miceArchives of Virology 2018; 163(8): 2073 doi: 10.1007/s00705-018-3837-3
45
Kiruthiga Mone, Ninaad Lasrado, Meghna Sur, Jay Reddy. Vaccines against Group B Coxsackieviruses and Their ImportanceVaccines 2023; 11(2): 274 doi: 10.3390/vaccines11020274
46
Wenlong Dai, Chao Zhang, Xueyang Zhang, Pei Xiong, Qingwei Liu, Sitang Gong, Lanlan Geng, Dongming Zhou, Zhong Huang. A virus-like particle vaccine confers protection against enterovirus D68 lethal challenge in miceVaccine 2018; 36(5): 653 doi: 10.1016/j.vaccine.2017.12.057
47
Aliyu Maje Bello, Yaowaluck Maprang Roshorm. Recent progress and advances towards developing enterovirus 71 vaccines for effective protection against human hand, foot and mouth disease (HFMD)Biologicals 2022; 79: 1 doi: 10.1016/j.biologicals.2022.08.007
48
Xiaoliang Li, Xizhu Xu, Jichen Li, Huanhuan Lu, Congcong Wang, Rui Wang, Jinbo Xiao, Ying Liu, Yang Song, Jingdong Song, Qiang Sun, Yong Zhang. Preparation and immunoprotective effects of a virus-like particle candidate vaccine of the dominant epidemic D3 genotype coxsackievirus A6 in ChinaBiosafety and Health 2024; 6(1): 28 doi: 10.1016/j.bsheal.2023.11.001
49
Hao-Yang Li, Jian-Feng Han, Cheng-Feng Qin, Rong Chen. Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in miceVaccine 2013; 31(32): 3281 doi: 10.1016/j.vaccine.2013.05.019
50
Qingwei Liu, Xin Tong, Zhong Huang. Towards broadly protective polyvalent vaccines against hand, foot and mouth diseaseMicrobes and Infection 2015; 17(2): 155 doi: 10.1016/j.micinf.2014.11.004
51
Rui-Yuan Cao, Da-Yong Dong, Rui-Ju Liu, Jian-Feng Han, Guang-Chuan Wang, Hui Zhao, Xiao-Feng Li, Yong-Qiang Deng, Shun-Ya Zhu, Xiao-Yu Wang, Fang Lin, Fu-Jun Zhang, Wei Chen, E-De Qin, Cheng-Feng Qin, Xia Jin. Human IgG Subclasses against Enterovirus Type 71: Neutralization versus Antibody Dependent Enhancement of InfectionPLoS ONE 2013; 8(5): e64024 doi: 10.1371/journal.pone.0064024
52
Roger Fernández, Aida Carreño, Rosa Mendoza, Antoni Benito, Neus Ferrer-Miralles, María Virtudes Céspedes, José Luis Corchero. Escherichia coli as a New Platform for the Fast Production of Vault-like Nanoparticles: An Optimized ProtocolInternational Journal of Molecular Sciences 2022; 23(24): 15543 doi: 10.3390/ijms232415543
53
D. Zhao, B. Sun, H. Jiang, S. Sun, F.T. Kong, Y. Ma, L. Jiang, L. Bai, X. Chen, P. Yang, C. Liu, Y. Xu, W. Su, W. Kong, F. Xu, C. Jiang. Enterovirus71 virus-like particles produced from insect cells and purified by multistep chromatography elicit strong humoral immune responses in miceJournal of Applied Microbiology 2015; 119(4): 1196 doi: 10.1111/jam.12922
54
Yu-Li Lin, Chun-I Yu, Yu-Chen Hu, Tze-Jiun Tsai, Yin-Chieh Kuo, Wei-Kuang Chi, Ae-Ning Lin, Bor-Luen Chiang. Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particlesVaccine 2012; 30(7): 1305 doi: 10.1016/j.vaccine.2011.12.081
55
Ling Xue, Jiangning Liu, Qi Wang, Chun Zhang, Longfu Xu, Jian Luo, Jian Wang, Chuan Qin, Yongdong Liu, Zhiguo Su. Purification and assembling a fused capsid protein as an enterovirus 71 vaccine candidate from inclusion bodies to pentamer-based nanoparticlesBiochemical Engineering Journal 2017; 117: 139 doi: 10.1016/j.bej.2016.10.009
56
Shiyang Sun, Liping Jiang, Zhenglun Liang, Qunying Mao, Weiheng Su, Huafei Zhang, Xiaojun Li, Jun Jin, Lin Xu, Dandan Zhao, Peihu Fan, Dong An, Ping Yang, Jingcai Lu, Xiuping Lv, Bo Sun, Fei Xu, Wei Kong, Chunlai Jiang. Evaluation of monovalent and bivalent vaccines against lethalEnterovirus71 andCoxsackievirusA16 infection in newborn miceHuman Vaccines & Immunotherapeutics 2014; 10(10): 2885 doi: 10.4161/hv.29823
57
Subrat Kumar Swain, Ayushman Gadnayak, Jatindra Nath Mohanty, Rachita Sarangi, Jayashankar Das. Does enterovirus 71 urge for effective vaccine control strategies? Challenges and current opinionReviews in Medical Virology 2022; 32(4) doi: 10.1002/rmv.2322
58
Linda H.L. Lua, Natalie K. Connors, Frank Sainsbury, Yap P. Chuan, Nani Wibowo, Anton P.J. Middelberg. Bioengineering virus‐like particles as vaccinesBiotechnology and Bioengineering 2014; 111(3): 425 doi: 10.1002/bit.25159
59
Fernando Martín, Aida Carreño, Rosa Mendoza, Pablo Caruana, Francisco Rodriguez, Marlon Bravo, Antoni Benito, Neus Ferrer-Miralles, M Virtudes Céspedes, José Luis Corchero. All-in-one biofabrication and loading of recombinant vaults in human cellsBiofabrication 2022; 14(2): 025018 doi: 10.1088/1758-5090/ac584d
60
Zhiqiang Ku, Jinping Shi, Qingwei Liu, Zhong Huang. Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71Journal of Virological Methods 2012; 186(1-2): 193 doi: 10.1016/j.jviromet.2012.06.025
61
Qianjin Feng, Yaqing He, Jiahai Lu. Virus-Like Particles Produced in Pichia Pastoris Induce Protective Immune Responses Against Coxsackievirus A16 in MiceMedical Science Monitor 2016; 22: 3370 doi: 10.12659/MSM.900380
62
Amanda Muñoz-Juan, Aida Carreño, Rosa Mendoza, José L. Corchero. Latest Advances in the Development of Eukaryotic Vaults as Targeted Drug Delivery SystemsPharmaceutics 2019; 11(7): 300 doi: 10.3390/pharmaceutics11070300
63
M. Laura Fabre, Paula N. Arrías, Tomás Masson, Matías L. Pidre, Víctor Romanowski. Emerging and Reemerging Viral Pathogens2020; : 197 doi: 10.1016/B978-0-12-814966-9.00011-1
64
Andris Zeltins. Construction and Characterization of Virus-Like Particles: A ReviewMolecular Biotechnology 2013; 53(1): 92 doi: 10.1007/s12033-012-9598-4
65
Ke Lyu, Rong Chen. Achievements, challenges and prospects for the development of broadly protective multivalent vaccines and therapeutic antibodies against hand, foot and mouth diseaseScience Bulletin 2015; 60(15): 1305 doi: 10.1007/s11434-015-0847-3
66
Puxuan Lu, BoPing Zhou. Radiology of Infectious Diseases: Volume 12015; : 127 doi: 10.1007/978-94-017-9882-2_17
67
Hsuen-Wen Chang, Chia-Chyi Liu, Min-Han Lin, Hui-Min Ho, Ya-Ting Yang, Yen-Hung Chow, Pele Chong, Charles Sia. Generation of murine monoclonal antibodies which cross-neutralize human enterovirus genogroup B isolatesJournal of Virological Methods 2011; 173(2): 189 doi: 10.1016/j.jviromet.2011.02.003
68
Fuxiao Liu, Xiaodong Wu, Lin Li, Zengshan Liu, Zhiliang Wang. Use of baculovirus expression system for generation of virus-like particles: Successes and challengesProtein Expression and Purification 2013; 90(2): 104 doi: 10.1016/j.pep.2013.05.009
69
António Roldão, Maria Candida M Mellado, Leda R Castilho, Manuel JT Carrondo, Paula M Alves. Virus-like particles in vaccine developmentExpert Review of Vaccines 2010; 9(10): 1149 doi: 10.1586/erv.10.115
70
Neil David Rawlings, Alan John Barrett, Alex Bateman. Asparagine Peptide LyasesJournal of Biological Chemistry 2011; 286(44): 38321 doi: 10.1074/jbc.M111.260026
71
Xiaoli Wang, Zhiqiang Ku, Xiang Zhang, Xiaohua Ye, Jinhuan Chen, Qingwei Liu, Wei Zhang, Chao Zhang, Zhenglin Fu, Xia Jin, Yao Cong, Zhong Huang, Julie K. Pfeiffer. Structure, Immunogenicity, and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty CapsidJournal of Virology 2018; 92(1) doi: 10.1128/JVI.01330-17
72
Fabiana Fernandes, Ana P Teixeira, Nuno Carinhas, Manuel JT Carrondo, Paula M Alves. Insect cells as a production platform of complex virus-like particlesExpert Review of Vaccines 2013; 12(2): 225 doi: 10.1586/erv.12.153
73
Minqing Gong, Hongtao Zhu, Jun Zhou, Chunting Yang, Jing Feng, Xiaojun Huang, Gang Ji, Honglin Xu, Ping Zhu, D. S. Lyles. Cryo-Electron Microscopy Study of Insect Cell-Expressed Enterovirus 71 and Coxsackievirus A16 Virus-Like Particles Provides a Structural Basis for Vaccine DevelopmentJournal of Virology 2014; 88(11): 6444 doi: 10.1128/JVI.00200-14
74
Yu-An Kung, Chuan-Tien Hung, Yen-Chin Liu, Shin-Ru Shih. Update on the development of enterovirus 71 vaccinesExpert Opinion on Biological Therapy 2014; 14(10): 1455 doi: 10.1517/14712598.2014.935330
75
Wei Zhang, Wenlong Dai, Chao Zhang, Yu Zhou, Pei Xiong, Shuxia Wang, Xiaohua Ye, Qingwei Liu, Dongming Zhou, Zhong Huang. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunityEmerging Microbes & Infections 2018; 7(1): 1 doi: 10.1038/s41426-018-0094-1
76
Haroldo Cid da Silva Junior, Cristiane Pinheiro Pestana, Ricardo Galler, Marco Alberto Medeiros. Solubility as a limiting factor for expression of hepatitis A virus proteins in insect cell-baculovirus systemMemórias do Instituto Oswaldo Cruz 2016; 111(8): 535 doi: 10.1590/0074-02760160153
77
Yujia Zhai, Danyang Zhang, Leiye Yu, Fang Sun, Fei Sun. SmartBac, a new baculovirus system for large protein complex productionJournal of Structural Biology: X 2019; 1: 100003 doi: 10.1016/j.yjsbx.2019.100003
78
Dandan Zhao, Bo Sun, Shiyang Sun, Bin Fu, Chuntian Liu, Dawei Liu, Yanfei Chu, Youlei Ma, Lu Bai, Yongge Wu, Yan Zhou, Weiheng Su, Ali Hou, Linjun Cai, Fei Xu, Wei Kong, Chunlai Jiang, Yongchang Cao. Characterization of human enterovirus71 virus-like particles used for vaccine antigensPLOS ONE 2017; 12(7): e0181182 doi: 10.1371/journal.pone.0181182
79
Dingmei Zhang, Jiayuan Lu, Jiahai Lu. Enterovirus 71 vaccine: close but still farInternational Journal of Infectious Diseases 2010; 14(9): e739 doi: 10.1016/j.ijid.2009.12.002